All conferences

OSP1 · 2014

Bellagio 2014

Toward a New, Open Source Pharmaceutical Industry

The first-ever global conference on open source pharma, where the movement's players met, formed a community, and forged alliances.

About the conference

OSP1 was convened to launch concrete initiatives to discover, develop, and commercialize medicines for the most pressing needs in our society through the use of open and inclusive research models.

Many of the participants had never met before. The meeting created ties, formed a community, and forged the alliances that would carry the open source pharma movement forward.

Convened
July 16–18, 2014
Venue
Rockefeller Foundation Bellagio Center
Focus
First global conference on open source pharma
Participants
22 invited leaders

Objectives & sessions

What the OSP1 programme set out to do.

Forge

Bring together the first-ever global conference on open source pharma and build a community around it.

Learn

Define open source pharma, relate it to alternative pharma approaches, and assess its applicability at each stage of the pipeline.

Act

Develop concrete projects and paths forward: a global online research platform, a global innovation prize, an end-to-end pipeline for the world's first open source drug, crowdfunding and other innovative financing, a joint project proposal, and a joint academic paper.

Participants

22 people took part in OSP1.

Show the full participant list
  • Arpana Agarwal
  • Urmi Bajpai — Delhi University
  • Manica Balasegaram — Médecins Sans Frontières
  • Jörg Bentzien — Boehringer-Ingelheim Pharmaceuticals
  • Samir Brahmachari — Open Source Drug Discovery
  • Sarah Dennis — McGill University
  • Robert Don — Drugs for Neglected Diseases Initiative
  • UC Jaleel — Open Source Drug Discovery
  • Peter Kolb — University of Marburg
  • John McKew — National Institutes of Health
  • Jaykumar Menon — McGill University
  • Bernard Munos — InnoThink and FasterCures
  • Ganesh Neelam — Sir Ratan Tata Trust
  • Sherwood Neiss — Crowdfund Capital Advisors
  • Piero Olliaro — World Health Organization
  • Melinda Richter — Janssen Labs / Johnson & Johnson
  • Tomasz Sablinski — Transparency Life Sciences
  • Zakir Thomas — Open innovation expert
  • Matthew Todd — University of Sydney and Open Source Malaria
  • Els Torreele — Open Society Foundations
  • Dimitrios Tzalis — European Lead Factory
  • John Wilbanks — Sage Bionetworks

Join the Movement. Shape the Future of Open Science.

Help advance open science through AI, global collaboration, and accessible healthcare. Volunteer or donate to make a lasting impact.